• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶3对miR-627-5p的抑制作用促进了缺氧诱导的肝细胞癌进展。

Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression.

作者信息

Wang Jun, Liu Runkun, Wang Yufeng, Mo Huanye, Niu Yongshen, Xu Qiuran, Liu Qingguang

机构信息

Department of Emergency, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.

出版信息

J Cancer. 2021 Jul 3;12(17):5320-5330. doi: 10.7150/jca.58697. eCollection 2021.

DOI:10.7150/jca.58697
PMID:34335948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8317525/
Abstract

Hepatocellular carcinoma (HCC) is one of the most common solid tumors globally. Our previous studies revealed that miR-627-5p suppresses HCC progression via targeting BCL3/CCND1 pathway. However, the molecular mechanism by which miR-627-5p was downregulated in HCC remains to be further elucidated. As a hallmark of solid tumors, hypoxia results in the rapid growth, strongly potential invasion and high frequent metastasis of cancer cells. Hypoxia-inducible factors (HIFs), mainly including HIF-1 and HIF-2, are the classical transcription factors which mediate hypoxia-related gene transcription. Here, we demonstrated that miR-627-5p was repressed by hypoxia in a HIF-1-dependent manner in HCC cells. But HIF-1 regulated miR-627-5p expression not directly through the hypoxia-response element (HRE) sites of MIR627 gene. In contrast, histone deacetylase 3 (HDAC3) was identified as a HIF-1 target gene, and the occupancy of HIF-1 to HRE site was essential for hypoxia-mediated HDAC3 induction. And upregulated HDAC3 was closely related to the malignant clinical and pathological characteristics and worse prognosis of HCC. Furthermore, HDAC3-mediated histone deacetylation in promoter region of MIR627 was critical for hypoxia-mediated miR-627-5p repression. And miR-627-5p mediated the effects of hypoxic condition on HCC progression. Thus, this study has revealed that miR-627-5p was repressed by hypoxia under the mediation of HDAC3 in HCC, and there existed a HIF-1α/HDAC3/miR-627-5p/BCL3/CCND1 signal pathway in HCC.

摘要

肝细胞癌(HCC)是全球最常见的实体瘤之一。我们之前的研究表明,miR-627-5p通过靶向BCL3/CCND1通路抑制HCC进展。然而,miR-627-5p在HCC中下调的分子机制仍有待进一步阐明。作为实体瘤的一个标志,缺氧导致癌细胞快速生长、强烈的侵袭潜能和高频率转移。缺氧诱导因子(HIFs),主要包括HIF-1和HIF-2,是介导缺氧相关基因转录的经典转录因子。在此,我们证明miR-627-5p在HCC细胞中以HIF-1依赖的方式被缺氧抑制。但HIF-1并非直接通过MIR627基因的缺氧反应元件(HRE)位点调节miR-627-5p的表达。相反,组蛋白去乙酰化酶3(HDAC3)被鉴定为HIF-1靶基因,HIF-1对HRE位点的占据对于缺氧介导的HDAC3诱导至关重要。并且HDAC3上调与HCC的恶性临床和病理特征及较差预后密切相关。此外,HDAC3介导的MIR627启动子区域组蛋白去乙酰化对于缺氧介导的miR-627-5p抑制至关重要。并且miR-627-5p介导了缺氧条件对HCC进展的影响。因此,本研究揭示了在HCC中miR-627-5p在HDAC3介导下被缺氧抑制,且HCC中存在HIF-1α/HDAC3/miR-627-5p/BCL3/CCND1信号通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/703add358352/jcav12p5320g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/5d09915c9294/jcav12p5320g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/50bfd73f62b9/jcav12p5320g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/a52e7511ef88/jcav12p5320g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/00bf3c17b679/jcav12p5320g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/964dceba710b/jcav12p5320g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/703add358352/jcav12p5320g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/5d09915c9294/jcav12p5320g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/50bfd73f62b9/jcav12p5320g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/a52e7511ef88/jcav12p5320g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/00bf3c17b679/jcav12p5320g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/964dceba710b/jcav12p5320g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9be7/8317525/703add358352/jcav12p5320g006.jpg

相似文献

1
Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression.组蛋白去乙酰化酶3对miR-627-5p的抑制作用促进了缺氧诱导的肝细胞癌进展。
J Cancer. 2021 Jul 3;12(17):5320-5330. doi: 10.7150/jca.58697. eCollection 2021.
2
Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma.MiR-199a-5p与HIF-1α的相互调节作用调控肝癌中的瓦博格效应
J Cancer. 2017 Mar 12;8(6):940-949. doi: 10.7150/jca.17496. eCollection 2017.
3
Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.缺氧通过 HIF-1α/miR-338-5p/IL-6 反馈环诱导结直肠癌耐药。
Mol Ther. 2019 Oct 2;27(10):1810-1824. doi: 10.1016/j.ymthe.2019.05.017. Epub 2019 Jun 4.
4
MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer.miRNA-646 介导的 HIF-1α 和 MIIP 之间的相互抑制作用促进胰腺癌的发生。
Oncogene. 2018 Mar;37(13):1743-1758. doi: 10.1038/s41388-017-0082-2. Epub 2018 Jan 18.
5
miR-138-5p Inhibits Vascular Mimicry by Targeting the HIF-1/VEGFA Pathway in Hepatocellular Carcinoma.miR-138-5p 通过靶向 HCC 中的 HIF-1/VEGFA 通路抑制血管拟态。
J Immunol Res. 2022 May 28;2022:7318950. doi: 10.1155/2022/7318950. eCollection 2022.
6
MicroRNA-627-5p inhibits the proliferation of hepatocellular carcinoma cells by targeting BCL3 transcription coactivator.microRNA-627-5p 通过靶向 BCL3 转录共激活子抑制肝癌细胞的增殖。
Clin Exp Pharmacol Physiol. 2020 Mar;47(3):485-494. doi: 10.1111/1440-1681.13218. Epub 2019 Dec 21.
7
Prognostic value and prospective molecular mechanism of miR-100-5p in hepatocellular carcinoma: A comprehensive study based on 1,258 samples.miR-100-5p在肝细胞癌中的预后价值及潜在分子机制:基于1258例样本的综合研究
Oncol Lett. 2019 Dec;18(6):6126-6142. doi: 10.3892/ol.2019.10962. Epub 2019 Oct 4.
8
Enhanced ROBO4 is mediated by up-regulation of HIF-1α/SP1 or reduction in miR-125b-5p/miR-146a-5p in diabetic retinopathy.增强的 ROBO4 是通过上调 HIF-1α/SP1 或降低糖尿病视网膜病变中的 miR-125b-5p/miR-146a-5p 来介导的。
J Cell Mol Med. 2019 Jul;23(7):4723-4737. doi: 10.1111/jcmm.14369. Epub 2019 May 15.
9
HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p.缺氧诱导因子 1A 通过 miR-100-5p 激活长链非编码 RNA RAET1K 的转录,从而调节肝癌细胞的缺氧诱导糖酵解。
Cell Death Dis. 2020 Mar 9;11(3):176. doi: 10.1038/s41419-020-2366-7.
10
miR-135b-5p Suppresses Androgen Receptor-Enhanced Hepatocellular Carcinoma Cell Proliferation via Regulating the HIF-2α/c-Myc/P27 Signals in vitro.miR-135b-5p通过体外调节HIF-2α/c-Myc/P27信号抑制雄激素受体增强的肝癌细胞增殖。
Onco Targets Ther. 2020 Oct 7;13:9991-10000. doi: 10.2147/OTT.S268214. eCollection 2020.

引用本文的文献

1
The lactate metabolism and protein lactylation in epilepsy.癫痫中的乳酸代谢与蛋白质乳酰化
Front Cell Neurosci. 2025 Jan 14;18:1464169. doi: 10.3389/fncel.2024.1464169. eCollection 2024.
2
Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age.BCL3 在癌症中的多效性作用:原癌基因的成熟。
Mol Cancer. 2024 Jan 9;23(1):7. doi: 10.1186/s12943-023-01922-8.
3
The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.组蛋白去乙酰化酶在肝细胞癌中的预后及临床病理意义:一项荟萃分析。

本文引用的文献

1
Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway.缺氧诱导的丝切蛋白1通过调节磷脂酶D1/蛋白激酶B通路促进肝细胞癌进展。
Clin Transl Med. 2021 Mar;11(3):e366. doi: 10.1002/ctm2.366.
2
Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.长非编码 RNA MAPKAPK5-AS1/PLAGL2/HIF-1α 信号通路促进肝细胞癌进展。
J Exp Clin Cancer Res. 2021 Feb 17;40(1):72. doi: 10.1186/s13046-021-01868-z.
3
Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma.
Clin Exp Med. 2023 Sep;23(5):1515-1536. doi: 10.1007/s10238-022-00934-w. Epub 2022 Nov 7.
4
Gene regulation by histone-modifying enzymes under hypoxic conditions: a focus on histone methylation and acetylation.组蛋白修饰酶在缺氧条件下的基因调控:以组蛋白甲基化和乙酰化为重点。
Exp Mol Med. 2022 Jul;54(7):878-889. doi: 10.1038/s12276-022-00812-1. Epub 2022 Jul 22.
缺氧诱导型泛素特异性肽酶13通过增强肝细胞癌中的Toll样受体4/髓样分化初级反应基因88/核因子κB通路促进肿瘤生长和转移。
Front Cell Dev Biol. 2020 Oct 19;8:587389. doi: 10.3389/fcell.2020.587389. eCollection 2020.
4
Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.化疗诱导 S100A10 募集 KDM6A 以促进 OCT4 介导的乳腺癌干性。
J Clin Invest. 2020 Sep 1;130(9):4607-4623. doi: 10.1172/JCI138577.
5
LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.低氧诱导的组蛋白去乙酰化酶 3 下调长链非编码 RNA RUNX1-IT1 抑制肝癌细胞的增殖和肿瘤干细胞样特性。
Cell Death Dis. 2020 Feb 5;11(2):95. doi: 10.1038/s41419-020-2274-x.
6
MicroRNA-627-5p inhibits the proliferation of hepatocellular carcinoma cells by targeting BCL3 transcription coactivator.microRNA-627-5p 通过靶向 BCL3 转录共激活子抑制肝癌细胞的增殖。
Clin Exp Pharmacol Physiol. 2020 Mar;47(3):485-494. doi: 10.1111/1440-1681.13218. Epub 2019 Dec 21.
7
Tumour evolution in hepatocellular carcinoma.肝细胞癌中的肿瘤演进。
Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):139-152. doi: 10.1038/s41575-019-0229-4. Epub 2019 Dec 2.
8
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.微小 RNA 和长链非编码 RNA 在肝癌耐药中的新兴作用。
Mol Cancer. 2019 Oct 25;18(1):147. doi: 10.1186/s12943-019-1086-z.
9
Identification of new hypoxia-regulated epithelial-mesenchymal transition marker genes labeled by H3K4 acetylation.鉴定受 H3K4 乙酰化调控的新的低氧上皮-间充质转化标记基因。
Genes Chromosomes Cancer. 2020 Feb;59(2):73-83. doi: 10.1002/gcc.22802. Epub 2019 Sep 3.
10
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.缺氧诱导因子促进乳腺癌干细胞在缺氧或细胞毒性化疗时的特化和维持。
Adv Cancer Res. 2019;141:175-212. doi: 10.1016/bs.acr.2018.11.001. Epub 2018 Dec 19.